However, bisphosphonate scintigraphy is the only non-invasive imaging method that can definitively confirm a diagnosis of transthyretin (ATTR) amyloidosis, after ruling out light chain (AL) amyloidosis. The gene discussed is TTR; the disease is amyloidosis.